- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07626086
Pilates Exercises on Balance, Fatigue and Quality of Life
Effect of Pilates Exercises on Balance, Fatigue and Quality of Life in Patients With Renal Transplantation
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Research Ethical Committee Faculty of Physical Therapy
- Telefonní číslo: 01151312322
- E-mail: eth.com@pt.cu.edu.eg
Studijní místa
-
-
-
Giza, Egypt, 12613
- Zatím nenabíráme
- Faculty of Physical Therapy
-
Kontakt:
- Telefonní číslo: 01151312322
- E-mail: eth.com@pt.cu.edu.eg
-
-
Beheira
-
Damanhur, Beheira, Egypt, 22511
- Nábor
- Damanhour Medical National Institute
-
Kontakt:
- MONA ZIETHAR
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
(1) Patients' age was ranged between 20-50 years old, (2) Both gender participated in this study, (3) All the patients were free from any neurological disorders, (4) All the patients were free from genitourinary infections, (5) All patients started the treatment program between 3 and 12 months following renal transplantation, (6) were not currently participating in any other regular physical exercise program, (7) Patients who were able to comprehend command and willing to participate in the study and (8) Informed consent was obtained from all patients enrolled in the trial.
Exclusion Criteria:
(1) Neuropathy issues, (2) Rheumatic diseases, (3) Orthopedic diseases, (4) Abdominal surgery of the upper or lower abdomen, (5) Patients who required acute respiratory intervention, (6) Patients who transferred to the intensive care unit, (7) Active smokers, (8) uncontrolled ABP, (9) Diabetics, (10) Chronic hepatitis, (11) Patients with pacemaker, (12) detection of reduced exercise tolerance, including tachycardia, shortness of breath, and feeling too tired or weak.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Pilates exercises Plus Conventional physical therapy program.
Study group (group A) (n =25) who received Pilates exercises 3 times per week in addition to conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and already taken medical care for 12 weeks.
|
Pilates exercises consisted of three parts: warm-up, the main part, and relaxation.
During the warm-up phase, exercises aimed at improving respiration and increasing the range of motion were performed.
The main phase consisted of Pilates exercises for the center of force and strengthening of the articular, pelvic, trunk, and limb muscles by 13 exercises: Bridging, Hundred, Roll Up, One Leg Circle (both ways), Rocker with closed legs, Single Straight Leg Stretch, Double Leg Stretch, Spine Stretch Forward, Single Leg Kick, Side Kick up and down, Side Kick circles, Rest position (stretch and relaxation), and Curling.
During the relaxation phase, stretching, relaxation, and breathing exercises were performed 3 times per week for 12 weeks.
Conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care (analgesics, antibiotics, wound care) for 12 weeks.
|
|
Experimentální: Conventional physical therapy program
Control group (group B) (n =25) who received conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care for 12 weeks.
|
Conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care (analgesics, antibiotics, wound care) for 12 weeks.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Borg Balance Scale
Časové okno: 12 Weeks
|
The Berg Balance Scale, possibly the most widely used balance-related measure, has gained popularity in clinical trials.
It provides information about patients' balance-related abilities and can be used to assess improvement or worsening after rehabilitation.
The BBS is a scale that includes scoring between 0 (not applicable) and 4 (normal performance) for the performance of 14 different tasks.
Scores from 0 to 20 indicate a loss of balance, scores from 21 to 40 suggest an acceptable level of balance, and scores from 41 to 56 indicate good balance on this scale, which is examined across 56 points
|
12 Weeks
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Modified Fatigue Impact Scale
Časové okno: 12 Weeks
|
Fatigue impact was assessed using the self-report Modified Fatigue Impact Scale (MFIS), which comprises a total score MFIS Total and three subscales (MFIS Physical, MFIS Cognitive and MFIS Psychosocial).
Higher scores indicate more fatigue impact.
The MFIS Total score (available range 0 - 84) was dichotomized at 38 to create two categories of participants, fatigued and non-fatigued
|
12 Weeks
|
|
Kidney Disease Quality of Life self-report (KDQOL-SF)
Časové okno: 12 Weeks
|
This questionnaire is used to assess the QOL of patients with kidney disease, It contains twenty-four questions covering a wide range of domains of human functioning in daily, occupational and social life.
It is a self-report measure, resulting from a subjective perception of one's health, functionality, and their QOL as directly related to having kidney disease.
Each answer in the questionnaire is assigned a specific number of points.
The scoring of answers in the KDQoL-SFTM questionnaire is carried out using a scale from 0 to 100 points.
The higher the value, the higher the QOL, and the lower the value, the worse the QOL.
|
12 Weeks
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 752017
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Transplantace ledvin
-
Fady M Kaldas, M.D., F.A.C.S.DokončenoHodnotí modulaci imunosuprese na Renal Recovery Post LTSpojené státy
-
Forest LaboratoriesDokončenoSyndrom systémové zánětlivé reakce (SIRS) | Augmented Renal Clearance (ARC)Spojené státy, Austrálie
-
Northwestern UniversityNational Cancer Institute (NCI)UkončenoRakovina ledvin | Hereditary Clear Cell Renal Cell CarcinomaSpojené státy
-
Guru SonpavdePfizer; Hoosier Cancer Research NetworkStaženoRakovina ledvin | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney CarcinomaSpojené státy
-
Philogen S.p.A.DokončenoClear Cell Renal Cell Carcinoma (ccRCC)Itálie
-
Mirati Therapeutics Inc.DokončenoClear-cell Renal Cell CarcinomaSpojené státy
-
Kousai Bio Co., Ltd.StaženoClear Cell Renal Cell Carcinoma (ccRCC)Čína
-
Massachusetts General HospitalTelix Pharmaceuticals, LtdZatím nenabírámeClear Cell Renal Cell Carcinoma (ccRCC) | ccRCCSpojené státy
-
Shang PanfengLanzhou University Second HospitalDokončenoClear Cell Renal Cell Carcinoma (ccRCC)Čína
-
Regeneron PharmaceuticalsNáborMetastatický karcinom prostaty odolný proti kastraci (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)Spojené státy